✦ LIBER ✦

C.21.02 Challenges in assessing cognition, function and neuropsychiatric status in clinical trials

✍ Scribed by J. Harrison

Book ID: 118595408
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 63 KB
Volume: 18
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(08)70966-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast Cancer Treatment and Cognitive Fu

Breast Cancer Treatment and Cognitive Functioning: Current Status and Future Challenges in Assessment

✍ Steven A. Castellon; Daniel H. S. Silverman; Patricia A. Ganz 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 192 KB

Assessing cognitive function in clinical

Assessing cognitive function in clinical trials of schizophrenia

✍ Jennifer H. Barnett; Trevor W. Robbins; Verity C. Leeson; Barbara J. Sahakian; E 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Cognitive dysfunction in schizophrenia is an important target for novel therapies. Effectively measuring the cognitive effects of compounds in clinical trials of schizophrenia could be a major barrier to drug development. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (

Assessing cognitive function in clinical

Assessing cognitive function in clinical trials: latest developments and future directions

✍ Keith Wesnes 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Assessing evidence from clinical trials

Assessing evidence from clinical trials in chronic hepatitis C

✍ B. R. Bacon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Assessing the interplay between cognitio

Assessing the interplay between cognition and gait in the clinical setting

✍ A. H. Snijders; C. C. Verstappen; M. Munneke; B. R. Bloem 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 154 KB

Cautionary tales in the clinical interpr

Cautionary tales in the clinical interpretation of trials assessing therapy-induced changes in health status

✍ I. A. Scott 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB